IL88719A0 - Novel crystal form of ciclosporin,its production and pharmaceutical compositions containing it - Google Patents

Novel crystal form of ciclosporin,its production and pharmaceutical compositions containing it

Info

Publication number
IL88719A0
IL88719A0 IL88719A IL8871988A IL88719A0 IL 88719 A0 IL88719 A0 IL 88719A0 IL 88719 A IL88719 A IL 88719A IL 8871988 A IL8871988 A IL 8871988A IL 88719 A0 IL88719 A0 IL 88719A0
Authority
IL
Israel
Prior art keywords
ciclosporin
production
pharmaceutical compositions
compositions containing
crystal form
Prior art date
Application number
IL88719A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL88719A0 publication Critical patent/IL88719A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL88719A 1987-12-21 1988-12-19 Novel crystal form of ciclosporin,its production and pharmaceutical compositions containing it IL88719A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (1)

Publication Number Publication Date
IL88719A0 true IL88719A0 (en) 1989-07-31

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88719A IL88719A0 (en) 1987-12-21 1988-12-19 Novel crystal form of ciclosporin,its production and pharmaceutical compositions containing it

Country Status (27)

Country Link
JP (1) JPH0791316B2 (es)
KR (1) KR100188305B1 (es)
AT (1) AT403163B (es)
AU (1) AU626274B2 (es)
BE (1) BE1002665A4 (es)
CA (1) CA1341396C (es)
CH (1) CH677926A5 (es)
CY (1) CY1799A (es)
DE (1) DE3843054C2 (es)
DK (1) DK175220B1 (es)
ES (1) ES2012580A6 (es)
FI (1) FI89065C (es)
FR (1) FR2624863B1 (es)
GB (1) GB2211848B (es)
GR (1) GR1002486B (es)
HK (1) HK102894A (es)
HU (1) HU203564B (es)
IE (1) IE62006B1 (es)
IL (1) IL88719A0 (es)
IT (1) IT1235356B (es)
LU (1) LU87409A1 (es)
MY (1) MY103943A (es)
NL (1) NL195096C (es)
NO (1) NO177228C (es)
NZ (1) NZ227384A (es)
SE (1) SE503174C2 (es)
SG (1) SG99494G (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
WO1993023010A1 (en) * 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
ES2229473T3 (es) 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1706095B1 (en) 2004-01-20 2008-12-24 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
JP6163482B2 (ja) 2011-05-27 2017-07-12 アラーガン、インコーポレイテッドAllergan,Incorporated シクロスポリンaの結晶形態、その調製方法、およびその使用のための方法
JP6204921B2 (ja) * 2011-11-15 2017-09-27 アラーガン、インコーポレイテッドAllergan,Incorporated シクロスポリンaの形態2およびその作製方法
AU2012339701B8 (en) * 2011-11-15 2017-11-16 Allergan, Inc. Autoclavable suspensions of cyclosporin A Form 2
EP3701939A1 (en) * 2011-11-15 2020-09-02 Allergan, Inc. Suspensions of cyclosporin a form 2
CA2856044C (en) 2011-11-15 2016-11-29 Allergan, Inc. Sustained action formulation of cyclosporin form 2
WO2024085235A1 (ja) * 2022-10-20 2024-04-25 中外製薬株式会社 環状ペプチドの結晶の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (es) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
AT403163B (de) 1997-11-25
GB2211848B (en) 1991-11-06
HUT49893A (en) 1989-11-28
FR2624863A1 (fr) 1989-06-23
AU626274B2 (en) 1992-07-30
SG99494G (en) 1994-10-28
HU203564B (en) 1991-08-28
IT1235356B (it) 1992-06-30
ES2012580A6 (es) 1990-04-01
GB2211848A (en) 1989-07-12
LU87409A1 (fr) 1989-07-07
NO177228C (no) 1995-08-09
ATA309588A (de) 1997-04-15
HK102894A (en) 1994-09-30
FI885869A (fi) 1989-06-22
KR890009975A (ko) 1989-08-05
DE3843054A1 (de) 1989-07-27
BE1002665A4 (fr) 1991-04-30
SE503174C2 (sv) 1996-04-15
JPH0791316B2 (ja) 1995-10-04
CY1799A (en) 1995-02-17
DE3843054C2 (de) 2003-08-21
SE8804570D0 (sv) 1988-12-19
FI885869A0 (fi) 1988-12-19
SE8804570L (sv) 1989-06-22
KR100188305B1 (ko) 1999-06-01
FI89065C (fi) 1993-09-30
DK705488A (da) 1989-06-22
DK175220B1 (da) 2004-07-12
NL195096C (nl) 2004-02-09
FR2624863B1 (fr) 1991-04-26
IE62006B1 (en) 1994-12-14
NO885625D0 (no) 1988-12-19
IT8848690A0 (it) 1988-12-20
JPH01211598A (ja) 1989-08-24
NZ227384A (en) 1991-09-25
MY103943A (en) 1993-10-30
AU2705588A (en) 1989-06-22
DK705488D0 (da) 1988-12-19
NO885625L (no) 1989-06-22
GR880100850A (el) 1994-03-31
NO177228B (no) 1995-05-02
FI89065B (fi) 1993-04-30
IE883779L (en) 1989-06-21
NL8803125A (nl) 1989-07-17
CA1341396C (en) 2002-11-05
GB8829556D0 (en) 1989-02-08
GR1002486B (el) 1996-12-09
CH677926A5 (es) 1991-07-15

Similar Documents

Publication Publication Date Title
IL88719A0 (en) Novel crystal form of ciclosporin,its production and pharmaceutical compositions containing it
EP0446961A3 (en) Stabilized pharmaceutical composition and its production
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
DE3569245D1 (en) Novel antibiotic nk84-0218 pharmaceutical compositions containing it and process for the production of the same
HUT47278A (en) Process for producing pyrrolo-benzimidazols and pharmaceutical compositions containing them
PT86516A (en) Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same
IL87089A (en) Derivatives of n-aminobutyl-n- phenylarylamides, their preparation and pharmaceutical compositions containing them
HUT50121A (en) Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
GR870093B (en) 8a- acylaminoergolines their production and pharmaceutical compositions containing them
IL81546A (en) N-(alpha-(4-diphenylalkyl-piperazin-1-ylmethyl))-purine-ethanol derivatives,their production and pharmaceutical compositions containing them
IL85624A0 (en) Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
HUT49115A (en) Process for producing new n-substituted mercapto-propanamides and pharmaceutical compositions containing them
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
GB8814476D0 (en) Production of cosmetic/pharmaceutical composition
IL84366A0 (en) 2,6-diamino-3-halogenbenzylpyridines,their manufacture and pharmaceutical compositions containing them
CY1752A (en) 8a-Acylaminoergoline its preparation and pharmaceutical compositions containing it
PT84542A (en) Process for preparing naphthothiazocinones and of pharmaceutical compositions containing the same
IL85524A0 (en) Heterocyclyl-2-propyn-1-amines and pharmaceutical compositions containing same
HUT47292A (en) Process for producing thieno-thiopiranes and pharmaceutical compositions containing them
ZA889540B (en) New cyclosporin crystal form,processes for its production,pharmaceutical compositions containing it and its use

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed